LGM
GBIO

Logos Global Management’s Generation Bio GBIO Stock Holding History

Logos Global Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,700
Closed -$482K – 60
2020
Q4 		$482K Buy
+1,700
New +$546K 0.04% 58
2020
Q3 		– Sell
-32,500
Closed -$6.83M – 52
2020
Q2 		$6.83M Buy
+32,500
New +$7.24M 1.36% 26

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Logos Global Management's GBIO Position: Q1 2021 in Review

Logos Global Management sold out of Generation Bio (GBIO) in Q1 2021, closing a stake of 1,700 shares — an estimated $482K sold.

Logos Global Management first reported a position in GBIO in Q2 2020 and held it in 2 quarters. The position peaked at $6.83M in Q2 2020. 88 funds tracked by Wall St. Rank hold GBIO as of Q1 2021.

  • Logos Global Management reported no remaining Generation Bio position as of Q1 2021 after selling out during the quarter.
  • Logos Global Management sold 1,700 Generation Bio shares in Q1 2021, an estimated $482K.
  • Logos Global Management first reported a position in Generation Bio in Q2 2020 and held it in 2 quarters.
  • Logos Global Management's Generation Bio position peaked at $6.83M in Q2 2020.
  • 88 funds tracked by Wall St. Rank held Generation Bio as of Q1 2021.

Based on Logos Global Management's 13F filing for Q1 2021, filed 17 May 2021.